OnKure Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
OnKure Therapeutics, Inc. has filed 399 SEC EDGAR filings since 08 Jan 2018

SEC filing history

Showing 126-150 of 399 matching filings.

Per page
25
Current page
6
SCHEDULE 13G/A File 005-92480

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92480

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92480

SCHEDULE 13G/A filing

Filing date
06 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92480

SCHEDULE 13G filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92480

SCHEDULE 13D/A filing

Filing date
21 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-282792

424B3

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-283693

S-8

Filing date
09 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92480

AMENDMENT NO. 1

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

ONKURE THERAPEUTICS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-282792

424B3

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-282792

424B3

Filing date
31 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282792

EFFECT filing

Filing date
30 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92480

AMENDMENT NO. 1

Filing date
28 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-282792

UPLOAD filing

Filing date
25 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92480

SC 13G/A filing

Filing date
23 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-527340

D filing

Filing date
21 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .